Ib-FUC significantly reduced blood glucose and increases insulin sensitivity.
Inflammatory response was remarkably mitigated by supplementary Ib-FUC.
Ib-FUC normalized hepatic HK, PK, GP, and G6Pase, and activated insulin signaling.
Ib-FUC alleviates inflammation via inactivation of JNK and IKK-β/NFκB pathways.
Ib-FUC is a novel functional factor for inflammation and insulin resistance.